Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C ε resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells

Journal of Neurochemistry

Volumn 93, Issue 3, 2005, Pages 549-559

  Lieb, Klaus ^a   Biersack, Lisa ^a   Waschbisch, Anne ^a   Orlikowski, Sonja ^a   Akundi, Ravi Shankar ^a   Candelario Jalil, Eduardo ^a   Hüll, Michael ^a   Fiebich, Bernd L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cytokine; Depression; Immunomodulation; Neuroinflammation; Neurotransmitter; Stress

Indexed keywords

3 (8 AMINOMETHYL 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL) 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CARBOXAMIDOTRYPTAMIN; ENZYME INHIBITOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PIMOZIDE; PROTEIN KINASE C EPSILON; SEROTONIN; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; CELL LINE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ASTROCYTOMA; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-6; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 14844334743     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03079.x     Document Type: Article

References (48)

1. Barnes N. M. and Sharp T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152.
2. Bonaccorso S., Lin A., Song C., Verkerk R., Kenis G., Bosmans E., Scharpe S., Vandewoude M., Dossche A. and Maes M. (1998) Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano) 10, 316-323.
3. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann. Biochem. 162, 156-157.
4. Das S. and Potter H. (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14, 447-456.
5. Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
6. Dean J. L., Brook M., Clark A. R. and Saklatvala J. (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274, 264-269.
7. Fiebich B. L. and Chrubasik S. (2004) Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine 11, 135-138.
8. Fiebich B. L., Mueksch B., Boehringer M. and Hull M. (2000a) Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. J. Neurochem. 75, 2020-2028.
9. Fiebich B. L., Schleicher S., Butcher R. D., Craig A. and Lieb K. (2000b) The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J. Immunol. 165, 5606-5611.
10. Fiebich B. L., Schleicher S., Spleiss O., Czygan M. and Hull M. (2001) Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J. Neurochem. 79, 950-958.
11. Frommberger U. H., Bauer J., Haselbauer P., Fraulin A., Riemann D. and Berger M. (1997) Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiat. Clin. Neurosci. 247, 228-233.
12. Gruol D. L. and Nelson T. E. (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15, 307-339.
13. Gschwendt M., Muller H. J., Kielbassa K., Zang R., Kittstein W., Rincke G. and Marks F. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199, 93-98.
14. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J. and Johannes F. J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 77-80.
15. Hagan J. J., Price G. W., Jeffrey P. et al. (2000) Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br. J. Pharmacol. 130, 539-548.
16. Harrison B. J., Olver J. S., Norman T. R. and Nathan P. J. (2002) Effects of serotonin and catecholamine depletion on interleukin-6 activation and mood in human volunteers. Hum. Psychopharmacol. 17, 293-297.
17. Hedlund P. B., Danielson P. E., Thomas E. A., Slanina K., Carson M. J. and Sutcliffe J. G. (2003) No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc. Natl Acad. Sci. USA 100, 1375-1380.
18. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
19. Hug H. and Sarre T. F. (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J. 291, 329-343.
20. Inoue T., Itoh S., Wakisaka S., Ogawa S., Saito M. and Morimoto T. (2002) Involvement of 5-HT7 receptors in serotonergic effects on spike afterpotentials in presumed jaw-closing motoneurons of rats. Brain Res. 954, 202-211.
21. Ito T., Ikeda U., Shimpo M., Yamamoto K. and Shimada K. (2000) Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells. Circulation 102, 2522-2527.
22. Krobert K. A. and Levy F. O. (2002) The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. Br. J. Pharmacol. 135, 1563-1571.
23. Kubera M., Simbirtsev A., Mathison R. and Maes M. (2000) Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiat. Res. 96, 255-266.
24. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-685.
25. Lieb K., Kaltschmidt C., Kaltschmidt K., Baeuerle P. A., Berger M., Bauer J. and Fiebich B. L. (1996) Interleukin-1b uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor a genes in the human astrocytoma cell line U373. J. Neurochem. 66, 1496-1503.
26. Lieb K., Fiebich B. L., Berger M., Bauer J. and Schulze-Osthoff K. (1997) The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J. Immunol. 159, 4952-4958.
27. Lieb K., Schaller H., Bauer J., Berger M., Schulze-Osthoff K. and Fiebich B. L. (1998) Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-1L-6. J. Neurochem. 70, 1577-1583.
28. Lieb K., Treffurth Y., Hamke M., Akundi R. S., von Kleinsorgen M. and Fiebich B. L. (2003) Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor. J. Neurochem. 86, 69-76.
29. Luo W., Sharif T. R. and Sharif M. (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res. 56, 4983-4991.
30. Mahe C., Bernhard M., Bobirnac I., Keser C., Loetscher E., Feuerbach D., Dev K. K. and Schoeffter P. (2004) Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Br. J. Pharmacol. 143, 404-410.
31. Manji H. K. and Lenox R. H. (2000) Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol. Psychiat. 48, 518-530.
32. Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marme D. and Schachtele C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 9194-9197.
33. Mossner R. and Lesch K. P. (1998) Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12, 249-271.
34. Norris J. G., Tang L. P., Sparacio S. M. and Benveniste E. N. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 152, 841-850.
35. Norum J. H., Hart K. and Levy F. O. (2003) Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J. Biol. Chem. 278, 3098-3104.
36. Pousset F., Fournier J., Legoux P., Keane P., Shire D. and Soubrie P. (1996) Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes. Brain Res. Mol. Brain Res. 38, 54-62.
37. Ravindran A. V., Griffiths J., Merali Z., Knott V. J. and Anisman H. (1999) Influence of acute tryptophan depletion on mood and immune measures in healthy males. Psychoneuroendocrinology 24, 99-113.
38. Roth B. L., Craigo S. C., Choudhary M. S., Uluer A., Monsma F. J. Jr, Shen Y., Meltzer H. Y. and Sibley D. R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268, 1403-1410.
39. Shimizu M., Nishida A., Zensho H., Miyata M. and Yamawaki S. (1998) Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes. Brain Res. 784, 57-62.
40. Soltoff S. P. (2001) Rottlerin is a mitochondrial uncouple: that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J. Biol. Chem. 276, 37 986-37 992.
41. Stowe R. L. and Barnes N. M. (1998) Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine. Neuropharmacology 37, 1611-1619.
42. Su B. and Karin M. (1996) Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8, 402-441.
43. Wang S. W., Pawlowski J., Wathen S. T., Kinney S. D., Lichenstein H. S. and Manthey C. L. (1999) Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. Res. 48, 533-538.
44. Way K. J., Chou E. and King G. L. (2000) Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21, 181-187.
45. Wery-Zennaro S., Zugaza J. L., Letourneur M., Bertoglio J. and Pierre J. (2000) IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. Oncogene 19, 1596-1604.
46. Wilkinson S. E., Parker P. J. and Nixon J. S. (1993) Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294, 335-337.
47. Wu Y., Shaghaghi E. K., Jacquot C., Pallardy M. and Gardier A. M. (1999) Synergism between interleukin-6 and interleukin-1beta in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 rats. Eur. Cytokine Netw. 10, 57-64.
48. Zhang J., Terreni L., De Simoni M. G. and Dunn A. J. (2001) Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem. Int. 38, 303-308.